<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mp ids='MP_0001845'>Inflammation</z:mp> underlies the etiology of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> is associated with <z:mp ids='MP_0001845'>inflammation</z:mp> and may be a risk marker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Cysteine is a metabolic product of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and a precursor of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="16856">glutathione</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>It is unknown whether cysteine is associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: The objective was to assess the associations between <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and cysteine and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> incidence in postmenopausal women </plain></SENT>
<SENT sid="5" pm="."><plain>DESIGN: Associations between <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and cysteine and incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in the Women's Health Initiative observational cohort were assessed by using a nested case-control design </plain></SENT>
<SENT sid="6" pm="."><plain>Cases and controls (n = 988/group) were matched for age (mean ± SD age: 67 ± 7 y), ethnicity (85.2% white, 8.9% black, 2.2% Hispanic/Latina, and 3.6% other), hysterectomy status, and date of blood draw </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> and cysteine were measured by HPLC with postcolumn fluorimetric detection </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Multivariate-adjusted ORs (95% CIs) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were 1.46 (1.05, 2.04) for the highest quartile of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (&gt;9.85 μmol/L) compared with the lowest quartile (≤6.74 μmol/L) (P = 0.02) and 0.57 (0.40, 0.82) for the highest quartile of cysteine (&gt;309 μmol/L) compared with the lowest quartile (≤260 μmol/L) (P = 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>The association with <z:chebi fb="0" ids="17230">homocysteine</z:chebi> was significant for proximal <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> (P = 0.008) but not for distal or <z:e sem="disease" ids="C1527408,C0034885" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">rectal tumors</z:e>, whereas the association with cysteine was significant for <z:e sem="disease" ids="C1527408,C0034885" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">rectal tumors</z:e> (P = 0.02), borderline for proximal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P = 0.06), and not significant for distal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The associations with both <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and cysteine were significant for localized <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P ≤ 0.01) but not for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: High plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> is associated with increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, whereas high cysteine is associated with decreased risk </plain></SENT>
<SENT sid="12" pm="."><plain>This trial was registered at clinicaltrials.gov as NCT 00000611 </plain></SENT>
</text></document>